Article
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
Thyroid : official journal of the American Thyroid Association - 1 May 2017
Moon Shinje, Song Young Shin, Kim Ye An, Lim Jung Ah, Cho Sun Wook, Moon Jae Hoon, Hahn Seokyung, Park Do Joon, Park Young Joo
Abstract excerpt
BACKGROUND: The presence of a telomerase reverse transcriptase (TERT) promoter mutation has been suggested as a potential prognostic marker for thyroid cancer, and a synergistic association with the BRAFV600E mutation has been demonstrated. The aim of this study was to verify the role of this genetic duet in papillary thyroid cancer (PTC). METHODS: Studies of the association of BRAFV600E and TERT promoter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
